Irvine, Calif. - Allergan Inc., contrary to popular belief, isn't fighting the U.S. Food and Drug Administration's allegations that statements in Botox Cosmetic advertisements are misleading, thus violating of the Food, Drug, and Cosmetic Act.
Answering Your Questions About Cosmeceutical Peptides
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
LC-OCT Demonstrates Non-Invasive Evaluation Capabilities of Dermal Fillers
The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice
Hair-Raising Challenges
Tailoring Aesthetic Treatments for Patients With Skin of Color